{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:54:35Z","timestamp":1767138875994,"version":"build-2238731810"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00108-018-0441-2","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T02:41:08Z","timestamp":1527043268000},"page":"668-673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Schilddr\u00fcse und Herz","Thyroid gland and the heart"],"prefix":"10.1007","volume":"59","author":[{"given":"U.","family":"Dischinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,23]]},"reference":[{"key":"441_CR1","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1067\/mhj.2001.119370","volume":"142","author":"J Auer","year":"2001","unstructured":"Auer J, Scheibner P, Mische T et\u00a0al (2001) Subclinical hyperthyroidism as a\u00a0risk factor for atrial fibrillation. Am Heart\u00a0J 142:838\u2013842","journal-title":"Am Heart J"},{"key":"441_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000486957","volume":"7","author":"L Bartalena","year":"2018","unstructured":"Bartalena L, Bogazzi F, Chiovato L et al (2018) 2018 European Thyroid Association (ETA) guidelines for the management of Amiodarone-associated thyroid dysfunction. Eur Thyroid\u00a0J 7:55\u201366","journal-title":"Eur Thyroid J"},{"key":"441_CR3","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cjca.2017.07.002","volume":"33","author":"C Beyer","year":"2017","unstructured":"Beyer C, Plank F, Friedrich G et\u00a0al (2017) Effects of hyperthyroidism on coronary artery disease: a computed tomography angiography study. Can J Cardiol 33:1327\u20131334","journal-title":"Can J Cardiol"},{"key":"441_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000438750","volume":"4","author":"B Biondi","year":"2015","unstructured":"Biondi B, Bartalena L, Cooper DS et\u00a0al (2015) The 2015 European Thyroid Association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism. Eur Thyroid\u00a0J 4:149\u2013163","journal-title":"Eur Thyroid J"},{"key":"441_CR5","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1210\/jc.2010-0180","volume":"95","author":"F Bogazzi","year":"2010","unstructured":"Bogazzi F, Bartalena L, Martino E (2010) Approach to the patient with amiodarone-induced thyrotoxicosis. J\u00a0Clin Endocrinol Metab 95:2529\u20132535","journal-title":"J Clin Endocrinol Metab"},{"key":"441_CR6","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1210\/jc.2017-00410","volume":"102","author":"L Chaker","year":"2017","unstructured":"Chaker L, Korevaar TIM, Rizopoulos D et\u00a0al (2017) Defining optimal health range for thyroid function based on the risk of cardiovascular disease. J\u00a0Clin Endocrinol Metab 102:2853\u20132861","journal-title":"J Clin Endocrinol Metab"},{"key":"441_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nrendo.2009.225","volume":"6","author":"J Cohen-Lehman","year":"2010","unstructured":"Cohen-Lehman J, Dahl P, Danzi S et al (2010) Effects of amiodarone therapy on thyroid function. Nat Rev Endocrinol 6:34\u201341","journal-title":"Nat Rev Endocrinol"},{"key":"441_CR8","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1001\/archinternmed.2012.402","volume":"172","author":"TH Collet","year":"2012","unstructured":"Collet TH, Gussekloo J, Bauer DC et\u00a0al (2012) Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 172:799\u2013809","journal-title":"Arch Intern Med"},{"key":"441_CR9","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1053\/j.ajkd.2013.10.009","volume":"63","author":"C Drechsler","year":"2014","unstructured":"Drechsler C, Schneider A, Gutjahr-Lengsfeld L et al (2014) Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients. Am J Kidney Dis 63:988\u2013996","journal-title":"Am J Kidney Dis"},{"key":"441_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1046\/j.0300-0664.2001.01457.x","volume":"56","author":"SE Eaton","year":"2002","unstructured":"Eaton SE, Euinton HA, Newman CM et al (2002) Clinical experience of amiodarone-induced thyrotoxicosis over a\u00a03-year period: role of colour-flow Doppler sonography. Clin Endocrinol (Oxf) 56:33\u201338","journal-title":"Clin Endocrinol (Oxf)"},{"key":"441_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ijcard.2012.09.064","volume":"168","author":"A Frey","year":"2013","unstructured":"Frey A, Kroiss M, Berliner D et\u00a0al (2013) Prognostic impact of subclinical thyroid dysfunction in heart failure. Int J Cardiol 168:300\u2013305","journal-title":"Int J Cardiol"},{"key":"441_CR12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ahj.2014.03.020","volume":"167","author":"B Gencer","year":"2014","unstructured":"Gencer B, Butler J, Bauer DC et\u00a0al (2014) Association of electrocardiogram abnormalities and incident heart failure events. Am Heart\u00a0J 167:869\u2013875.e3","journal-title":"Am Heart J"},{"key":"441_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ehf2.12084","volume":"3","author":"T Hayashi","year":"2016","unstructured":"Hayashi T, Hasegawa T, Kanzaki H et\u00a0al (2016) Subclinical hypothyroidism is an independent predictor of adverse cardiovascular outcomes in patients with acute decompensated heart failure. ESC Heart Fail 3:168\u2013176","journal-title":"ESC Heart Fail."},{"key":"441_CR14","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1161\/01.CIR.0000048124.64204.3F","volume":"107","author":"G Iervasi","year":"2003","unstructured":"Iervasi G, Pingitore A, Landi P et al (2003) Low-T3 syndrome: a\u00a0strong prognostic predictor of death in patients with heart disease. Circulation 107:708\u2013713","journal-title":"Circulation"},{"key":"441_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000469708","volume":"6","author":"R Janssen","year":"2017","unstructured":"Janssen R, Muller A, Simonides WS (2017) Cardiac thyroid hormone metabolism and heart failure. Eur Thyroid\u00a0J 6:130\u2013137","journal-title":"Eur Thyroid J"},{"key":"441_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ahj.2013.10.012","volume":"167","author":"EJ Kim","year":"2014","unstructured":"Kim EJ, Lyass A, Wang N et\u00a0al (2014) Relation of hypothyroidism and incident atrial fibrillation (from the Framingham Heart Study). Am Heart\u00a0J 167:123\u2013126","journal-title":"Am Heart J"},{"key":"441_CR17","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","volume":"116","author":"I Klein","year":"2007","unstructured":"Klein I, Danzi S (2007) Thyroid disease and the heart. Circulation 116:1725\u20131735","journal-title":"Circulation"},{"key":"441_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cpcardiol.2015.04.002","volume":"41","author":"I Klein","year":"2016","unstructured":"Klein I, Danzi S (2016) Thyroid disease and the heart. Curr Probl Cardiol 41:65\u201392","journal-title":"Curr Probl Cardiol"},{"key":"441_CR19","doi-asserted-by":"publisher","first-page":"e1159","DOI":"10.1097\/MD.0000000000001159","volume":"94","author":"N Ning","year":"2015","unstructured":"Ning N, Gao D, Triggiani V et al (2015) Prognostic role of hypothyroidism in heart failure: a meta-analysis. Medicine (Baltimore) 94:e1159","journal-title":"Medicine (Baltimore)"},{"key":"441_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.14797\/mdcj-13-2-60","volume":"13","author":"PM Osuna","year":"2017","unstructured":"Osuna PM, Udovcic M, Sharma MD (2017) Hyperthyroidism and the heart. Methodist Debakey Cardiovasc\u00a0J 13:60\u201363","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"441_CR21","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD et\u00a0al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891\u2013975","journal-title":"Eur J Heart Fail"},{"key":"441_CR22","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1001\/jama.2010.1361","volume":"304","author":"N Rodondi","year":"2010","unstructured":"Rodondi N, Den Elzen WP, Bauer DC et\u00a0al (2010) Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304:1365\u20131374","journal-title":"JAMA"},{"key":"441_CR23","doi-asserted-by":"publisher","first-page":"e7895","DOI":"10.1136\/bmj.e7895","volume":"345","author":"C Selmer","year":"2012","unstructured":"Selmer C, Olesen JB, Hansen ML et\u00a0al (2012) The spectrum of thyroid disease and risk of new onset atrial fibrillation: a\u00a0large population cohort study. BMJ 345:e7895","journal-title":"BMJ"},{"key":"441_CR24","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1210\/jc.2013-4184","volume":"99","author":"C Selmer","year":"2014","unstructured":"Selmer C, Olesen JB, Hansen ML et al (2014) Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a\u00a0large population study. J\u00a0Clin Endocrinol Metab 99:2372\u20132382","journal-title":"J Clin Endocrinol Metab"},{"key":"441_CR25","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1210\/jc.2006-1877","volume":"92","author":"CW Siu","year":"2007","unstructured":"Siu CW, Zhang XH, Yung C et al (2007) Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a\u00a0prospective echocardiographic study. J\u00a0Clin Endocrinol Metab 92:1736\u20131742","journal-title":"J Clin Endocrinol Metab"},{"key":"441_CR26","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1056\/NEJMc1709989","volume":"377","author":"DJ Stott","year":"2017","unstructured":"Stott DJ, Rodondi N, Bauer DC et\u00a0al (2017) Thyroid hormone therapy for older adults with subclinical hypothyroidism. N\u00a0Engl J Med 377:e20","journal-title":"N Engl J Med"},{"key":"441_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.14797\/mdcj-13-2-55","volume":"13","author":"M Udovcic","year":"2017","unstructured":"Udovcic M, Pena RH, Patham B et\u00a0al (2017) Hypothyroidism and the heart. Methodist Debakey Cardiovasc\u00a0J 13:55\u201359","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"441_CR28","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1210\/jc.2010-2693","volume":"96","author":"T Vadiveloo","year":"2011","unstructured":"Vadiveloo T, Donnan PT, Cochrane L et\u00a0al (2011) The Thyroid Epidemiology, Audit, and Research Study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism. J\u00a0Clin Endocrinol Metab 96:1344\u20131351","journal-title":"J Clin Endocrinol Metab"}],"updated-by":[{"DOI":"10.1007\/s00108-018-0532-0","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T00:00:00Z","timestamp":1544486400000}}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-018-0441-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-018-0441-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-018-0441-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T01:39:24Z","timestamp":1558575564000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-018-0441-2"}},"subtitle":["Pathophysiologische Hintergr\u00fcnde, diagnostische und therapeutische Konsequenzen","Pathophysiological background, diagnostic and therapeutic consequences"],"short-title":[],"issued":{"date-parts":[[2018,5,23]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["441"],"URL":"https:\/\/doi.org\/10.1007\/s00108-018-0441-2","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,23]]},"assertion":[{"value":"23 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2018","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum zu:\n                      Internist 2018\n                      \n                      Im Originalbeitrag ist Tab.\u00a02 leider fehlerhaft. Wir bitten Sie die nachfolgende korrekte Darstellung zu \u2026","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"U.\u00a0Dischinger und M.\u00a0Fassnacht geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}